489 TWT-101: a phase 1 study of the novel HPK1 inhibitor CFI-402411 in patients with advanced cancer
oleh: Judy Wang, Omid Hamid, Siqing Fu, Johanna Bendell, Anna Spreafico, Alexander Spira, Kyriakos Papadopoulos, Brigette Ma, Mark Bray, Graham Fletcher, Glenn Michelson, Emily Roberts-Thomson
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.